VANDA PHARMACEUTICALS INC. 2016 EQUITY INCENTIVE PLANVanda Pharmaceuticals Inc. • June 15th, 2017 • Pharmaceutical preparations
ContractVanda Pharmaceuticals Inc. • June 15th, 2017 • Pharmaceutical preparations • England and Wales
Neither this document, nor any stock option agreement connected with it, is an approved prospectus for the purposes of section 85(1) of the Financial Services and Markets Act 2000 (“FSMA”) and no offer of transferable securities to the public (for the purposes of section 102B of FSMA) is being made in connection with the UK Sub-Plan to the Vanda Pharmaceuticals Inc. Amended and Restated 2016 Equity Incentive Plan (the “Sub-Plan”). The Sub-Plan is exclusively available to bona fide employees and former employees of Vanda Pharmaceuticals Inc., Vanda Pharmaceuticals Limited and any other UK Subsidiary.
